BRTX · BioRestorative Therapies Inc
United States · RS rating 75 · As of 2026-10-14
| Price | 1.50 USD |
|---|---|
| 1-day change | -5.7% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 3 / 98 / 36 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 35 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +66.1% |
| Distance from 52-week high | +46.5% |
| Market cap (USD) | $5.7M |